Perspectives on Enquiry & Evidence
Cytel's blog featuring the latest industry insights.
May 7, 2024
Here we explore the evolution and impact of market exclusivity policies in the EU and US, highlighting their role in...
Read article
April 10, 2024
Orphan Drug Designation for Rare Diseases
Orphan drug designation is a regulatory status granted to pharmaceuticals developed for the treatment of rare diseases....
Read article